Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial.

Clinical Trials 92

Clinical Trials Research and Development Therapy Policy 92

Veriheal

OCTOBER 20, 2023

Here’s what you missed this week in cannabis and psychedelic news. Michigan’s decision to end pre-employment drug testing is motivated by the fact that the state already legalized recreational cannabis back in 2018. With cannabis completely legal to use, the state found it unfair to continue penalizing applicants for using it.

Policy 92

Policy Clinical Trials Research and Development Dispensary 92

Canna Care Docs

OCTOBER 3, 2023

Conventional medication methods such as opiates may help terminal patients focus on more palliative treatment options and goals in order to better one’s comfort and overall quality of life during this time. However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Veriheal

MAY 25, 2023

What was once used as an ideal anesthetic for monkeys could soon be competing with cannabis as a medical aid. Currently, the only ketamine treatment for depression that insurance will cover is esketamine (Spravato) , an FDA-approved nasal spray. In Manhattan alone, 12 clinics have already opened their doors. million by 2027.

Medicine 89

Medicine Blood Pressure Therapy Clinical Trials 89

Cannabis Law Report

JUNE 30, 2021

LONDON–(BUSINESS WIRE)– Fourfive , the CBD and nutrition brand loved by athletes and those leading an active lifestyle, today called on the UK’s sports governing bodies to stop sitting if on the fence and conduct clinical trials into the effectiveness of CBD and medicinal cannabis in professional sport.

Medicine 75

Medicine Clinical Trials CBD Sleep 75

Cannabis Law Report

AUGUST 10, 2021

A new article published in Drugs: Education, Prevention and Policy discusses the importance, and challenges, of racial equity within the resurgent field of psychedelic-assisted mental health treatment. With these injustices, and many more, it is clear why many BIPOC might be disinterested in participating in such studies today.

Clinical Trials 105

Clinical Trials Research and Development Therapy Treatment 105

Cannabis Law Report

AUGUST 29, 2019

PUBLISHER: CANNABIS LAW REPORT. It has been just over a month since the public comment period closed in the wake of the public hearing held by the FDA, “Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds”. AUTHOR: Scott Lloyd Counsel Offit?Kurman Attorneys At Law.

Food 45

Food Hemp CBD Clinical Trials 45

Cannabis Law Report

FEBRUARY 24, 2022

Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions. Physicians still need SAP approval on a patient-by-patient basis and SAP approval is only granted when other available treatments prove ineffective.

Therapy 52

Therapy Access Clinical Trials Treatment 52

Cannabis Law Report

AUGUST 30, 2021

The research could provide the foundation for tailored medical psychedelic treatments. “In America the USDA [United States Department of Agriculture] has fast tracked psilocybin treatment. Recent international trials at Johns Hopkins Centre for Psychedelic and Consciousness Research have revealed psilocybin’s potential.

Clinical Trials 105

Clinical Trials Collective Therapy Treatment 105

Cannabis Law Report

AUGUST 17, 2021

Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. Food and Drug Administration (FDA) has granted orphan drug designation to ganaxolone in TSC. percent, consistent with the Marigold Phase 3 CDKL5 deficiency disorder trial of 24.5 RADNOR, Pa.–(BUSINESS Data Highlights.

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Canna Law Blog

JANUARY 22, 2020

The company is also running a phase IIb clinical trial of its patented formulation, COMP360, which we covered in a blog post back in 2018. In that post, I explained how the Food and Drug Administration (FDA) approval process works and why this trial is so interesting and important.

Clinical Trials 116

Clinical Trials Decriminalization Microdosing Food 116

Cannabis Law Report

JUNE 24, 2022

The legislation from Senate President Nicholas Scutari (D), who has long championed cannabis reform in the Garden State, would further create a system of licensed businesses to provide psilocybin services in supervised settings. Full story at.

Clinical Trials 52

Clinical Trials Legalization Research and Development Therapy 52

CannaMD

MAY 12, 2021

It’s a favorite cliche of stoner parodies — but one that doesn’t do justice to the potential benefits of medical marijuana for the treatment of eating disorders. This leads to severe food restrictions and physical wasting. Sufferers feel they are overweight even when dangerously underweight.

Marijuana 119

Marijuana Therapy Conditions Food 119

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. Food and Drug Administration (FDA) approved esketamine (a component of Ketamine and sold under the brand name Spravato) for treatment-resistant depression.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

MAY 28, 2022

The firm represents clients around the world in major industries including energy and natural resources; financial services and capital markets; food and agribusiness; healthcare, life sciences and education; real estate, development and construction; and technology, manufacturing and transportation.

Research and Development 52

Research and Development Therapy Clinical Trials Legalization 52

Cannabis Law Report

AUGUST 3, 2021

Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. Cybin makes no medical, treatment or health benefit claims about Cybin’s proposed products.

Clinical Trials 105

Clinical Trials Events Treatment Banking 105

Cannabis Law Report

JULY 29, 2021

OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

The Cannigma

MARCH 7, 2022

Yet cannabinol (CBN), the first cannabinoid ever discovered by modern scientists, is slowly making a comeback in the cannabis industry. . Of course, this plant is now known to be marijuana (or Type I cannabis), which is still commonly used for sleep and analgesia today. The best online schools for medical cannabis training.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

Cannabis Law Report

AUGUST 6, 2021

Cannabinoids are the naturally occurring compounds found in the Cannabis plant. There are over 480 different Cannabinoids in the Cannabis plant. CBD does not give its users the ‘high’ typically associated with Cannabis. The ‘high’ found in Cannabis comes from another useful Cannabinoid: THC. Anti-seizure Properties.

CBD 105

CBD Wellness and Beauty Treatment Pharmaceutical 105

Cannabis Law Report

NOVEMBER 23, 2021

The new patent, US Patent No 11,180,517, covers methods of treating treatment-resistant depression (TRD) with crystalline psilocybin as well as with oral dosage forms of crystalline psilocybin with an excipient. This is COMPASS’s 10 th patent overall, with five now granted in the US, two in the UK, one in Germany and two in Hong Kong.

Clinical Trials 52

Clinical Trials Therapy Research and Development Media 52

The Blunt Truth

DECEMBER 23, 2020

In quick succession, the Food & Drug Administration (FDA) announced yesterday, December 22 nd , that it issued five warning letters to companies for selling products containing CBD in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). Actions Speak Louder Than Words.

CBD 103

CBD Food Safety Clinical Trials 103

Cannabis Law Report

OCTOBER 13, 2021

The PCT filing also includes support for future research programs respecting various systems which seek to minimize negative side effects in psychedelic psychotherapy patients, methods that enable lower and sub-psychedelic doses without impacting treatment efficacy and increasing the long-term efficacy of psychedelic sessions. About Cybin.

Clinical Trials 52

Clinical Trials Research and Development Treatment Conditions 52

Veriheal

OCTOBER 13, 2020

Cannabis has been identified as an effective alternative treatment for some gastrointestinal disorders…but does that include IBD and IBS? . The main triggers of this syndrome include food that the body can’t tolerate (such as gluten), stress, and hormones (women with IBS can experience it at its worst during menstrual periods). .

Digestion 120

Digestion Treatment Conditions Research and Development 120

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. This is the largest trial ever conducted in psilocybin therapy, and it was done amid the lockdowns and challenges of the COVID pandemic. million, or $0.79 million, or $2.61

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

JULY 24, 2021

“The groundbreaking progress that we’ve seen from the Multidisciplinary Association for Psychedelic Studies (MAPS) in its Phase 3 clinical trials of MDMA-assisted psychotherapy for Post-Traumatic Stress Disorder (PTSD), including receiving Breakthrough Therapy Designation from the Food and Drug Administration (FDA), shows great promise to date.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Cannabis Law Report

NOVEMBER 19, 2021

“These additional patent filings are key as PsyBio moves towards the initiation of appropriately approved safety and efficacy clinical trials for our selected compounds within the production and manufacturing arena, for the Company as well as for our investors.” Vigorous scientific research and clinical trials are needed.

Clinical Trials 52

Clinical Trials Research and Development Events Safety 52

Cannabis Law Report

SEPTEMBER 1, 2021

The company recently became the industry’s first firm to list on the NYSE American exchange and their psilocybin clinical trial for depression is making excellent progress. After Approval, It’s Off to Treatment Clinics. FTRP ) is the current industry leader of in-person treatment clinics.

Research and Development 102

Research and Development Therapy Clinical Trials Pharmaceutical 102

CannaMD

OCTOBER 29, 2020

But, while contraband cannabis might not be a concern, the very real threat that candy poses to the American population is alarming. So this Halloween, we invite you to join us as CannaMD takes a brave look at five times candy – in all its high-glycemic glory –was way scarier than cannabis. Cannabis: 1. Cannabis: 2.

Research and Development 92

Research and Development Blood Pressure Data Clinical Trials 92

Veriheal

APRIL 11, 2022

Cannabis, despite being widely available for medical and recreational consumers across the United States, remains one of the most understudied plants. federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Fortunately, the U.S. territories.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

DECEMBER 11, 2021

Since Thailand launched its first cannabis clinic in August 2019, the Public Health Ministry has opened over 500 more nationwide. “More than 40,000 patients have used cannabis to treat their respective illnesses. . “More than 40,000 patients have used cannabis to treat their respective illnesses.

Oil 52

Oil Blood Pressure Concentrates Patients 52

Cannabis Law Report

OCTOBER 9, 2021

As traditional treatment has proven inadequate at both the individual and public health level, the Commonwealth has a responsibility to research alternative options. Please join us in cosponsoring this legislation, thank you.

Therapy 52

Therapy Clinical Trials Treatment Legislation 52

Cannabis Law Report

AUGUST 4, 2019

Proactive Investor writes, Recent developments have indicated that new treatments derived from these mind-altering substances are garnering new attention from the investment community. Echoes of cannabis. Say the word “psychedelic” and most people will immediately conjure up images of tie-dyed hippy types taking magic mushrooms.

Medicine 40

Medicine Therapy Clinical Trials Treatment 40

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Clinical Trials and Human Subject Protections. Zachary Fuchs.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

SpeedWeed

SEPTEMBER 4, 2021

Titled “Proposed Adjustments to the Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2021,” the article specifically includes some major changes for cannabis and psilocybin. Some states in the U.S.

DEA 52

DEA Research and Development Clinical Trials Extraction 52

Cannabis Law Report

JULY 4, 2021

CLR contributor, Brian Cusack, writes… The legalization of cannabis in Ireland has become a popular discussion around the world. While countries like Canada, Uruguay, and some states in America have legalized recreational cannabis, this isn’t a trend that has reached Ireland yet. or none at all to qualify with legal status.

THC 105

THC CBD Legalization Oil 105

Cannabis Law Report

AUGUST 26, 2019

According to a recent study published in the journal, Addiction found that use of marijuana/cannabis is increasing across the United States, though this rise is not connected to the legalization of marijuana in participating states. CBD occurs in cannabis. The approval is based on the research and clinical trials.

Chronic Pain 45

Chronic Pain Clinical Trials Epilepsy Conditions 45

MedicalJane

JUNE 29, 2018

Food and Drug Administration (FDA) had approved only three cannabinoid-based medicines. None of the approved drugs contain, or are derived from, the whole cannabis plant. It is also the first FDA approval of a drug for the treatment of patients with Dravet syndrome. a Canada-based medical cannabis firm.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53